Get help paying for your medicines
Bristol Myers Squibb is committed to helping patients with access to our medicines.
Intended only for U.S. residents 18 years or older
Help understanding your coverage
What is and is not covered by your insurance can be hard to understand. We may be able to help you find out how your insurance plan covers your Bristol Myers Squibb prescription medicines. This includes benefits investigation and prior authorization support, as well as what your out-of-pocket costs might be.
Help with out-of-pocket costs
Even with insurance, affording medication can be difficult. If you have commercial insurance, we may be able to help you pay your out-of-pocket costs for prescribed Bristol Myers Squibb medicines.
Help with patient assistance
Some Bristol Myers Squibb medications are available free of charge. If you are struggling to make ends meet financially, do not have insurance that pays for your Bristol Myers Squibb medication, and meet other requirements, we may be able to help.
Patient support that speaks your language
Call center translation assistance for different languages
Translators are available in many languages. If you have been prescribed a BMS medication, contact your BMS patient program representative to learn more. |
If you, or someone you know, have possibly experienced a side effect or have a product complaint while taking a Bristol Myers Squibb product, please contact us.
(toll free U.S. only)
As of 2019, Bristol Myers Squibb and Celgene have merged. If you or someone you know have possibly experienced a side effect or have a product complaint while taking a legacy Celgene product, please contact us.
(toll free U.S. only)
Patient support resources
For additional patient support resources and information pertaining to Bristol Myers Squibb medications, please refer to the individual product listings below.
ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)
CAMZYOS® (mavacamten)
COBENFYTM (xanomeline and trospium chloride)
ELIQUIS® (apixaban)
EMPLICITI® (elotuzumab)
IDHIFA® (enasidenib)
INREBIC® (fedratinib)
ISTODAX® (romidepsin)
NULOJIX® (belatacept)
ONUREG® (azacitidine tablets)
OPDIVO® (nivolumab)
OPDUALAGTM (nivolumab and relatlimab-rmbw)
ORENCIA® (abatacept)
POMALYST® (pomalidomide)
REBLOZYL® (luspatercept-aamt)
REVLIMID® (lenalidomide)
SOTYKTU® (deucravacitinib)
SPRYCEL® (dasatinib)
THALOMID® (thalidomide)
VIDAZA® (azacitidine)
YERVOY® (ipilimumab)
ZEPOSIA® (ozanimod)